Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27583386 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL1834611 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL1840460 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL3291304 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL20526404 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| Fluoride SCHEMBL11519479 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL1845796 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL6690910 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL20509901 | 0.95 | TDP1 (0.36) | TDP1TSHRALDH1A1FFAR1CPT2 | |
| SCHEMBL1615049 | 0.90 | TSHR (0.39) | TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515186-B1 | ECDYSOZOANS TRAP | INNOC SRL (BE) | 2025-11-26 | — | — | EP | disclosed |
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | disclosed |
| US-20250135459-A1 | Tray Device | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-05-01 | — | — | US | disclosed |
| EP-4164481-B1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2024-10-16 | — | — | EP | disclosed |
| US-12048316-B2 | Sweetener and flavor compositions, methods of making and methods of use thereof | EPC NATURAL PRODUCTS CO., LTD. (CN) | 2024-07-30 | — | — | US | disclosed |
| US-12029228-B2 | Sweetener and flavor compositions, methods of making and methods of use thereof | EPC Natural Products Co., Ltd (CN) | 2024-07-09 | — | — | US | disclosed |
| US-11985994-B2 | Sweetener and flavor compositions, methods of making and methods of use thereof | EPC Natural Products Co., Ltd (CN) | 2024-05-21 | — | — | US | disclosed |
| WO-2024050389-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-07 | — | — | WO | disclosed |
| US-11849742-B2 | Tasteful natural sweetener and flavor | EPC NATURAL PRODUCTS CO., LTD. (CN) | 2023-12-26 | — | — | US | disclosed |
| US-20230337934-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2023-10-26 | — | — | US | disclosed |
| CN-106047516-B | Environment-friendly type oil sludge and sand cleansing composition and preparation method thereof | 青岛中孚达环境科技开发有限公司 | 2018-12-21 | — | — | CN | disclosed |
| WO-2018054974-A1 | ECDYSOZOANS TRAP | DOMOBIOS (BE) | 2018-03-29 | — | — | WO | disclosed |
| US-20180077917-A1 | ECDYSOZOANS TRAP | DOMOBIOS (BE) | 2018-03-22 | — | — | US | disclosed |
| US-9775843-B2 | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders | Grünenthal GmbH (DE) | 2017-10-03 | — | — | US | disclosed |
| US-20170121285-A1 | Selective androgen receptor modulators | RADIUS HEALTH INC (US) | 2017-05-04 | — | — | US | disclosed |
| CN-106047516-A | Environment-friendly oily silt cleaning agent composition and preparation method thereof | 青岛中孚达环境科技开发有限公司 | 2016-10-26 | — | — | CN | disclosed |
| US-20080009099-A1 | System and method of monitoring contamination | ENTEGRIS, INC. | 2008-01-10 | — | — | US | disclosed |
| CN-1289171-C | System and method for monitoring contamination | EXTRACTION SYSTEMS INC (US) | 2006-12-13 | — | — | CN | disclosed |
| CN-1575194-A | System and method for monitoring contamination | EXTRACTION SYSTEMS INC (US) | 2005-02-02 | — | — | CN | disclosed |
| CN-1145370-A | Olefin polymerization catalyst and process for producing polyolefin using the same | SUMITOMO CHEMICAL CO (JP) | 1997-03-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121285-A1 | Selective androgen receptor modulators | AR, SHBG, FSHR | TDP1 4382/4885TSHR 274/4885ALDH1A1 1511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.